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eTable1: Features of the databases included in the study 









NHS-linkedregional database(Northern and Central 
Region of Jutland) – community and in/out-patient 
hospital setting  
2000-2010 ICD-10 ATC 1,559,718 
ERD Italy 
NHS-linked regional database (Emiglia Romagna 
region) – community setting 
2005-2010 ICD-9 CM ATC 6,079,798 
HSD-CSD-LPD Italy 
General practicenationwide database – community 
setting  
2000-2010 




General practicenationwide database – community and 
hospital setting 
2005-2009 ICD-10 GM ATC 7,285,935 
IPCI Netherlands 
General practicenationwide database – community 
setting  
1998-2010 ICPC and freetext ATC 1,016,632 
PHARMO Netherlands Nationwide record linkagesystem – community setting 1999-2009 ICD-9 CM ATC 4,625,868 
THIN UK 
Nationwide general practicedatabase – community 
setting 
1997-2010 READand free text BNF/ Multilex 6,951,894 
Abbreviations: ATC- Anatomic Therapeutic Chemical drug classification; BNF- British National Formulary codes; ERD- Emilia-Romagna Database; GEPARD-  German 
PharmacoepidemiologicalResearch Database;  HSD-CSD-LPD- Health Search Database-Cegedim-Strategic Data-Longitudinal Patient Database; ICD-9 CM- International classification of Diseases, 9th 
edition, clinical modification; ICD-10- International classification of Diseases, 10th edition; ICD-10 GM- International classification of Diseases, 10th edition, German modification; ICPC- International 




















Legend: Ventricular Arrhythmia (VA) includes both ventricular tachycardia (VT) and fibrillation (VF). VT is a sequence of three or more beats in a row, with wide QRS complex (QRS ≥120 ms) at a 
ventricular rate exceeding 100 beats/min. If the rhythm lasts more than 30 seconds or requires termination earlier due to hemodynamic instability, it is known as a sustained ventricular tachycardia. If the 
fast rhythm self-terminates within 30 seconds, it is considered a non-sustained ventricular tachycardia. VT can evolve to VF that is a rapid, chaotic, non-repetitive waveform usually preceded by rapid VT 
and in which there is uncoordinated contraction of the cardiac muscle of the ventricles. VF is clinically associated with loss of effective blood circulation and, if not immediately treated, leads to death.For 
this analysis, VA was considered as two separated outcomes: non-fatal and fatal VA with the latter defined as death within 48 hours from the event of interest. In our study, CA was analyzed as part of 
VA as well as separate outcome. All cases of CA with successful resuscitation were considered as non-fatal VA, while CAs in which the patient died within 48 hours from the beginning of symptoms were 






Diagnosisof VA AND (Procedure done to treat/diagnose VA OR Prodromic symptom) 
Diagnosis of VF AND (Procedure done to treat/diagnose VA OR Prodromic symptom) 
Diagnosis of resuscitated CA AND (Procedure done to treat/diagnose VA OR Prodromic symptom) 
 
Diagnosis of fatal CA,VT, VF 













eTable2: Unified Medical Language-driven identification of terminology specific codes for ventricular arrhythmia and cardiac 
arrest 
UMLS concept Preferred term of concept ICD-9 ICD-10 ICD-10GM ICPC RCD v2 
Ventricular arrhythmia 
C0085612 Ventricular arrhythmia 
    
328..00, 328Z.00 
C0042514 Tachycardia, Ventricular 427.1 I47.2 I47.2 K79005 G571.00 
C0030591 Paroxysmal ventricular tachycardia 427.1 
   
G571.11 
C0152173 Ventricular Flutter 427.42 
  K80014, K84011 
G574100 
C0155710 Ventricular fibrillation and flutter 427.4 I49.0 I49.0 
 
G574.00, G574z00 























C0340513 Cardiac arrest as a complication of care 
    
SP11000 
C0600228 Cardiopulmonary Arrest 427.5 
   
G575.11 
C1260909 Cardiorespiratory failure as a complication of care 
    
SP11200 
C0397419 Direct current defibrillation 
    
7L1H.00, 7L1H.11, 
7L1H.12, 7L1H.13 
C0436588 O/E - collapse -cardiac arrest 
    
2241.00 
Abbreviations: ICD-9- International Classification of Disease, 9th version; ICD-10- International Classification of Disease, 10th version; ICD-10 GM- International Classification of Disease, 10th version, 
German modification; ICPC- International Classification of Primary Care code; RDC v2.- Read code version 2; UMLS- Unified Medical Language System
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eTable3: Coding algorithms for covariates included in the study 
Well-known risk factors for VA 
Covariate name Search criteria Time frame Notes 







It includes cardiomyopathies and 
channelopathies 




Coronary heart disease Dx or RX 
Anytime prior 
to ID 
ATC: C01D* as proxy of disease 











ATC: C09A-D*, C07*, C08*, 
C02A-K*, C02N* as proxy of 
disease. Two systolic blood 
pressure measurements with 
exceeding 140 were considered 
to denote hypertension. 




Antiarrhythmia drug use Rx 
Anytime prior 
to ID 
See Table S3 for ATC codes 
Electrolytic imbalance 




It includes hypocalcemia, 
hypokalemia and 
hypomagnesemia 
Use of QT prolonging drugs Rx 
90 days prior 
to ID 
Drugs with established 
TdPliability, based on 
CredibleMeds list** 
See Table S4 for ATC codes 
Concomitant use of QT 
prolonging drugs other than 
drugs under study 
Rx 
90 days prior 
to ID 
See Table S5 for ATC codes 
Concomitant use of medications 
inducing hypokalemia 
Rx 
90 days prior 
to ID 
See Table S6 for ATC codes 
Potential risk factors for VA 












Chronic respiratory disease DX or Rx 
Anytime prior 
to ID 
ATC: R03 as proxy of disease 








Diabetes mellitus Dx or Rx 
Anytime prior 
to ID 
ATC: A10* as proxy of disease 
Hyperthyroidism Dx or Rx 
Anytime prior 
to ID 
ATC: H03B* as proxy of disease 
Hypothyroidism Dx or Rx 
Anytime prior 
to ID 
ATC: H03A*, H03C* as proxy of 
disease 
Lipid metabolism disorders Dx or Rx 
Anytime prior 
to ID 
ATC: C10* as proxy of disease 
Obesity Dx or BMI≥ 30 or Rx 
Anytime prior 
to ID 
ATC: A08* as proxy of disease 








Abbreviations: Dx- diagnosis; ID- index date; Rx- prescription; VA: ventricular arrhythmia  
* Except for atrial fibrillation/flutter, conduction disorders, QT prolongation, ventricular arrhythmia and sudden cardiac death. ** 



















































eTable4: Anti-arrhythmia drugs 








Quinidine, combinations excl. psycholeptics C01BA51 
























eTable5:Drugs with established torsadogenic liability 
Drug ATC code 
Amiodarone C01BD01 





























eTable6: Drugs known to induce hypokalemia  












Bendroflumethiazide and potassium C03AB01 
Hydroflumethiazide and potassium C03AB02 
Hydrochlorothiazide and potassium C03AB03 
Chlorothiazide and potassium C03AB04 
Polythiazide and potassium C03AB05 
Trichlormethiazide and potassium C03AB06 
Cyclopenthiazide and potassium C03AB07 
Methyclothiazide and potassium C03AB08 
Cyclothiazide and potassium C03AB09 
Chlorothiazide, combinations C03AH01 
Hydroflumethiazide, combinations C03AH02 






Furosemide and potassium C03CB01 
Bumetanide and potassium C03CB02 
Ethacrynic acid C03CC01 
Muzolimine C03CD01 
Etozolin C03CX01 





























































Abbreviations:ERD - Emilia-Romagna Database; GEPARD-German Pharmacoepidemiological Research Database; HSD - Health 







HSD: 1,240,561   Total:28,760,406 
IPCI: 1,016,632 
PHARMO: 4,625,868  
THIN: 6,951,894 
 









Incident antibiotic users free of cancer before cohort 









Cases among incident antibiotic users 
currently exposed to azithromycin/amoxicillin/ 
other antibiotics  
 
AzithromycinAmoxicillin   Any other antibiotic  
            30                   165                 1,026 









Controls among incident antibiotic users 
currently exposed to azithromycin/amoxicillin/ 
other antibiotics  
 
AzithromycinAmoxicillin   Any other antibiotic  
        1,344                  370                 52,543 
